首页> 外文期刊>Anti-cancer agents in medicinal chemistry >Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs.
【24h】

Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs.

机译:新型三萜双醌和1,4-蒽二酮类似物的合成,分子靶标和抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Novel substituted triptycene bisquinones and 1, 4-anthracenediones were synthesized and screened for their anti-cancer activities. A number of analogs were synthesized utilizing various synthetic transformations and found to elicit interesting antitumor effects. Analogs included water-soluble pro-drugs and ammonium salts. These potent antitumor drugs are DNA topoisomerase inhibitors that induce DNA strand breaks, inhibit DNA, RNA and protein syntheses and reduce tumor cell proliferation in the nanomolar range in vitro. They induce cytochrome c release, caspase-9, -3 and -8 activities, poly(ADP)-ribose polymerase-1 (PARP) cleavage, and internucleosomal DNA fragmentation by a mechanism which involves caspase-2 activation but not Fas signaling. Moreover, these drugs remain effective in multidrug-resistant tumor cells and have the advantage of blocking nucleoside transport and inducing a rapid loss of mitochondrial transmembrane potential. Based on their effects in tumor cells and isolated mitochondria, itis hypothesized that these drugs might, directly and indirectly, target components of the permeability transition pore to induce mitochondrial permeability transition and the release of proapoptotic factors. This review provides a summary of synthetic efforts and mechanistic endeavor.
机译:合成了新型取代的三萜双醌和1,4-蒽二酮,并筛选了它们的抗癌活性。利用各种合成转化合成了许多类似物,并发现它们引起了有趣的抗肿瘤作用。类似物包括水溶性前药和铵盐。这些有效的抗肿瘤药物是DNA拓扑异构酶抑制剂,可在体外诱导DNA链断裂,抑制DNA,RNA和蛋白质合成并减少肿瘤细胞在纳摩尔范围内的增殖。它们通过涉及caspase-2激活而不是Fas信号传导的机制诱导细胞色素c释放,caspase-9,-3和-8活性,聚(ADP)-核糖聚合酶-1(PARP)裂解和核小体DNA断裂。而且,这些药物在对多药耐药的肿瘤细胞中仍然有效,并且具有阻断核苷转运并诱导线粒体跨膜电位快速丧失的优势。根据它们对肿瘤细胞和分离的线粒体的作用,推测这种药物可能直接或间接地靶向通透性转换孔的成分,从而诱导线粒体通透性转换和促凋亡因子的释放。这篇综述总结了综合的努力和机制的努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号